Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Arix co-leads a $58 million Series A investment in new Group Business, VelosBio Inc., bringing core portfolio[1] to 15 companies
Arix commits $11 million (£8.4 million)[2] for 11.2% ownership stake
Co-investment with strategic partner Takeda an... Biopharmaceuticals, Oncology, Venture Capital, Personnel Arix Bioscience, VelosBio
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news